Get started
Author

Olga B. Nesmeyanova

Observed names: O B Nesmeyanova, O Nesmeyanova, O. B. Nesmeyanova, O. Nesmeyanova, O.B. Nesmeyanova, Olga Nesmeyanova, Несмеянова О. Б., О. Б. Несмеянова
Observed institution: Regional Clinical Hospital No 4
ORCID: 0000-0002-5599-8248
Observed ORCID: 0000-0002-5599-8248
OpenAlex ID: A5110919953
On the Terminology of Spondyloarthritis
2015 · Sh. F. Erdes, V. V. Badokin, et al. · Rheumatology Science and Practice · 59
Guidelines for the Assessment of Disease Activity and Functional Status in Patients With Ankylosing Spondylitis in Clinical Practice
2017 · T. V. Dubinina, I. Z. Gaidukova, et al. · Rheumatology Science and Practice · 42
Spondyloarthritis: modern terminology and definitions
2019 · Sh F Erdes, A P Rebrov, et al. · Terapevticheskii arkhiv · 38
The Results of a Phase Iii Comparative Clinical Trial of Rituximab (acellbia® and Mabthera®) in Rheumatoid Arthritis (the Biora Study)
2016 · E. L. Nasonov, E. V. Zonova, et al. · Rheumatology Science and Practice · 35
Use of Nonsteroidal Anti-inflammatory Drugs and Biological Agents for the Treatment of Axial Spondyloarthritides. Recommendations of the Spondyloarthritis Study Group of Experts, All-russian Public Organization «the Association of Rheumatology of Russia»
2017 · I. Z. Gaidukova, A. P. Rebrov, et al. · Rheumatology Science and Practice · 25
Efficacy and safety of netakimab, anti-IL-17A monoclonal antibody, in patients with ankylosing spondylitis. Results of phase III international, multicenter, randomized double-blind clinical trial BCD-085-5/ASTERA
2020 · V. I. Mazurov, I. Z. Gaydukova, et al. · Rheumatology Science and Practice · 19
PDF
Effectiveness and safety of BCD180, anti-TRBV9+ T-lymphocytes monoclonal antibody in patients with active radiographic axial spondyloarthritis: 36-week results of double-blind randomized placebo-controlled phase II clinical study ELEFTA
2024 · E. L. Nasonov, V. I. Mazurov, et al. · Rheumatology Science and Practice · 18
PDF
Efficacy and safety of levilimab in combination with methotrexate in subjects with rheumatoid arthritis: Results of phase II AURORA study
2021 · V. I. Mazurov, E. G. Zotkin, et al. · Rheumatology Science and Practice · 18
PDF
Long-term efficacy and safety of netakimab in the treatment of ankylosing spondylitis: results of Phase III international, multicenter, randomized double-blind clinical trial BCD-085-5/ASTERA
2020 · V. I. Mazurov, Sh. F. Erdes, et al. · Modern Rheumatology Journal · 17
PDF
The Efficacy and Safety of BCD-180, an Anti-TRBV9+ T cell Monoclonal Antibody, in Patients with Active Radiographic Axial Spondyloarthritis: 36-week Results from the Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study ELEFTA
2025 · E. L. Nasonov, V. I. Mazurov, et al. · Doklady Biochemistry and Biophysics · 16
Evaluation of the Effectiveness of a Nonsteroidal Anti-inflammatory Drug (nsaid) Selection Algorithm Based on the Analysis of Risk Factors for Drug-induced Complications in Real Clinical Practice: the Results of the All-russian Principle Project (applicat
2017 · A. E. Karateev, A. M. Lila, et al. · Rheumatology Science and Practice · 15
Effectiveness and safety of levilimab in combination with methotrexate in treatment of patients with active rheumatoid arthritis resistant to methotrexate monotherapy (double-blinded randomized placebo controlled phase III clinical study SOLAR)
2021 · V. I. Mazurov, M. A. Korolev, et al. · Modern Rheumatology Journal · 14
PDF
Factors affecting the results of analgesic therapy. Results of the Russian multicentre study of NOTE (NSAID: Open-label Trial of Efficacy)
2018 · A E Karateev, E Yu Pogozheva, et al. · Terapevticheskii arkhiv · 13
PDF
The Efficacy and Safety of Rituximab Biosimilar (acellbia®) in Rheumatoid Arthritis as the First Biological Agent: Results of Phase Iii (alterra) Clinical Trial
2017 · E. L. Nasonov, V. I. Mazurov, et al. · Rheumatology Science and Practice · 13
A phase III study of BCD-055 compared with innovator infliximab in patients with active rheumatoid arthritis: 54-week results from the LIRA study
2019 · Alexander M. Lila, Vadim I. Mazurov, et al. · Rheumatology International · 12
Pharmacological treatment options for osteoarthritis: focus on symptomatic slow-acting drugs for osteoarthritis (SYSADOA) and individual patient characteristics: Resolution of the International Expert Meeting
2019 · A. M. Lila, L. I. Alekseeva, et al. · Modern Rheumatology Journal · 11
PDF
TUMOR NECROSIS FACTOR-α INHIBITORS IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS
2016 · S. A. Lapshina, T. V. Dubinina, et al. · Rheumatology Science and Practice · 10
Long-term efficacy and safety of netakimab in patients with active ankylosing spondylitis: results of three years of use in the international multicentre, randomized, double-blind, phase III clinical trial BCD-085-5/ASTERA
2024 · V. I. Mazurov, Sh. F. Erdes, et al. · Modern Rheumatology Journal · 9
PDF
Remission in Axial Spondyloarthritis: Definition and Evaluation Tools (recommendations of the Spondyloarthritis Study Group of Experts, All-russian Public Organization «the Association of Rheumatology of Russia»)
2018 · I. Z. Gaidukova, A. P. Rebrov, et al. · Rheumatology Science and Practice · 9
Use of Nonsteroidal Anti-inflammatory Drugs for the Treatment of Axial Spondyloarthritis, Including Ankylosing Spondylitis, Monitoring Their Efficacy and Safety (draft Guidelines of the Expert Spondyloarthritis Diagnosis and Treatment Group)
2016 · I. Z. Gaidukova, A. P. Rebrov, et al. · Rheumatology Science and Practice · 8
Comparative efficacy and safety of infliximab biosimilar (BCD-055) and innovator infliximab in patients with ankylosing spondylitis (results of international, multiple-center, double-blind phase I and phase III clinical studies)
2017 · D. E. Karateev, V. I. Mazurov, et al. · Modern Rheumatology Journal · 6
PDF
The Educational Program for Patients With Osteoporosis and Its Impact on Adherence to Treatment: Results of a Multicenter Randomized Trial
2012 · L P Evstigneeva, O M Lesnyak, et al. · Osteoporosis and Bone Diseases · 6
Efficacy and Safety of Levilimab in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis: 56-Week Results of Phase III Randomized Double-Blind Placebo-Controlled Trial SOLAR
2024 · V. I. Mazurov, E. L. Nasonov, et al. · Doklady Biochemistry and Biophysics · 5
Efficacy, safety and prospects of using a combination of native type II collagen, methylsulfonylmethane, boswellic acids, vitamin C and vitamin D3 in knee osteoarthritis: a resolution of the Expert panel
2024 · Vadim I. Mazurov, Liudmila I. Alekseeva, et al. · Terapevticheskii arkhiv · 5
PDF
Management of patients with rheumatoid arthritis in real clinical practice: Switching from interleukin 6 receptor inhibitors to interleukin 6 inhibitor (olokizumab)
2023 · A. A. Baranov, I. B. Vinogradova, et al. · Rheumatology Science and Practice · 5
PDF
Works count: 65
Citation count: 492
H-index: 13
I10-index: 17
Year
Topic
Type